PG's Modest Growth Outlook Raises Valuation Concerns
The Procter & Gamble Company (PG) enters fiscal 2027 with strong brands and high cash generation, but its growth profile remains subdued. The company's growth outlook is modest, with expected organic and all-in sales to rise 1-3% and core earnings per share projected to be flat to up 3%. Management's midpoint for core EPS is $7.00.
PG trades above key Zacks industry benchmarks even as earnings expectations point to low-single-digit progress. The company's valuation leaves little room for error, with a price-to-earnings ratio of 20.3X forward 12-month earnings versus 18.4X for the Zacks sub-industry and 17.3X for the Zacks Consumer Staples sector.
P&G's productivity helps offset margin pressure, but core gross margin fell 40 basis points and core operating margin declined 70 basis points in fiscal 2026. The company expects about $1 billion of after-tax pressure from raw materials, energy, transportation, and related costs in fiscal 2027.
PG innovation supports selective growth, with the upgraded Tide original liquid formula moving from declining sales to high-single-digit growth by the fiscal fourth quarter after P&G improved product performance without raising the price. The company's cash returns add shareholder support, with fiscal 2026 operating cash flow reaching $19.56 billion and adjusted free cash flow was $15.84 billion.